Endoscopic sclerotherapy has been used to control acute variceal haemorrhage which persists despite conservative therapy, prevent recurrent variceal haemorrhage in patients with a history of oesophageal haemorrhage, and to prevent a haemorrhage in patients with oesophageal varices who never bled.
INITIAL MANAGEMENT
Emergency endoscopic sclerotherapy can be performed immediately, at the time of the first diagnostic endoscopy, as preferred and recommended by our group or it can be delayed until the variceal haemorrhage has been controlled by conservative measures with or without the use of a pharmacologic agent or balloon tamponade. The use of immediate sclerotherapy requires a high degree of skill. We recommend its use whenever possible, since it provides instant control of haemorrhage. If these conditions are not fullfilled, we recommend pharmacological therapy or balloon tamponade and transfer of the patient to a specialist center. FOLLOW-UP (years) Figure 1 Cumulative survival curve using the method of KAPLAN-MEIER for the controlled randomized trial comparing the SENGSTAKEN-BLAKEMORE tube with emergency endoscopic sclerotherapy during emergency.
13 Table 3 Aetiology of the intra-and prehepatic block of prospective evaluation of immediate endoscopic injection sclerosis (IES) (n 232; Jan. 1, 1982- (Table 2) 1 '2 The cumulative survival curve using the method of KAPLAN-MEIER (Figure 1) demonstrates a statistically significant difference in favour of sclerotherapy (IEIS) after six months (p <0.05) and a higher significance after 36 months (p <0.0005).
We prospectively treated 232 patients from January 1, 1982 Spleno-renal (WARREN) 2 12.5
Porto-caval (end-to-side) 0 0 54 (24%) 10 18.5 Thus, IEIS during emergency endoscopy is established as a primary therapeutic mode to successfully control bleeding oesophageal varices. It appears to be superior to elective sclerotherapy. In spite of that we recommend this strategy only for a very experienced operator and endoscopist who must be available day and night and who also has an experienced endoscopy team with at least two additional persons to hand.
Elective Endoscopic Sclerotherapy Although repeated injection sclerotherapy is the most widely practised long-term treatment after variceal bleeding, it has not yet been proved to be the single most effective form of management. Five major controlled trials (Table 5) have evaluated long-term endoscopic sclerotherapy for the prevention of rebleeding4-s. In all these studies the frequency of rebleeding was reduced in sclerotherapy patients, although in three trials the difference to the control group was only significant when the total number of the bleeding episodes were considered rather than the number of patients who bled. However, up to 50% of patients rebleed on chronic sclerotherapy, although most of the rebleeding occurs before complete eradication or protection by scar tissue of the varices has been achieved and is of minor severity. The Thus, similar survival in both groups is not surprising ( Figure 5 ). The Copenhagen (Table 8) .
However, rebleeding during initial and long-term injection sclerotherapy occurs in 23 to 55% and remains a problem, even if it is of minor intensity. Therefore, a surgical approach to the so-called "sclerotherapy failures" has been discussed and recently investigated in controlled randomized trials. These randomized studies showed contradictory results ( (Figure 7) . In a few cases with portal pressure over 40cm H20 an emergent or urgent narrow lumen meso-caval shunt is carried out. CHILD-PUGH A-and -B-patients are considered for an elective shunt operation according to the criteria listed in Table 10 : sonographic volume of the liver should be between 1000 and 2500ml. Portal perfusion rate is measured by sequential scintigraphy; if it is more than 30%, the patient is considered for distal splenorenal shunt. If portal perfusion rate is between 10 and 30%, the patient is considered for a non-selective shunt. The preferred non-selective shunt is the narrow lumen meso-caval interposition shunt (NLMS: 10-12mm ring enforced PTFE-prothesis). Coeliac angiography should exclude stenosis of the hepatic artery and/or coeliac axis as well as "portal pseudoperfusion". Liver biopsy performed at laparoscopy should not show activity of the liver disease. Table 9 Selection criteria for elective narrow lumen mesocaval shunt interposition (NLMS) or a distal splenorenal shunt (DSRS) in cirrhotics with recurrence of haemorrhage from oesophago-gastric varices 1. Liver volume, sonographically determined as 1000-2500 ml 2. Portal perfusion 10-30% at sequential scintigraphy 3. No activity or progression of cirrhosis seen at laparoscopy and biopsy 4. No stenosis of the hepatic arterial circulation, and suitable lumen and length of the splenic vein, found at angiographic studies Figure 8 . The two curves are significantly (p < 0.01) different in favour of patients selected for shunt after sclerotherapy had failed. 
